Title: FMci-Family Medicine - Common Issues: COPD; Hypertension; Endocrine Disorders

Faculty: Herbert L. Muncie, Jr., M.D., Merri Lou Pendergrass, M.D., Ph.D.

Original Release Date: July 1, 2020  Expiration Date: July 1, 2023

TOPIC 1: Chronic Obstructive Pulmonary Disease (COPD): Evaluation and Treatment

Upon completion of this session, using the ACCP GOLD guidelines, the AACVPR practice guidelines and the evidence-based reports from Clinical Evidence, the participant should be able to: ^{EBM, GL, COMP}

1. Appraise patient specific data to determine if they meet diagnostic criteria for COPD.
2. Analyze the role of cigarette smoking in the etiology and natural history of COPD.
3. Formulate a treatment plan for the stages of COPD.
4. Recommend the follow-up required to assess the therapeutic efficacy of the treatment options.

TOPIC 2: Evaluation and Treatment of Hypertensive Patients

Upon completion of this session, using the most recent JNC Guidelines, the Cochrane Abstract Database and the evidence-based reports from Clinical Evidence, the participant should be able to: ^{EBM, GL, COMP}

1. Employ the non-pharmacologic treatment options to manage hypertension.
2. Specify the pharmacologic treatment options for patients with compelling indications based upon JNC Guidelines.
3. Formulate the therapeutic goal for controlling blood pressure in different patient populations and the combination of medications that can achieve that goal.
4. Distinguish the side effect risks for each class of antihypertensive medications.

TOPIC 3: Common Endocrine Disorders

Upon completion of this session, the participant should be able to: ^{EBM, GL, COMP}

1. Recognize, evaluate and treat common endocrine abnormalities and employ Endo Society Guidelines to include:
   1. Hypoglycemia,
   2. Hypercalcemia,
   3. Low testosterone,
   4. Adrenal masses.

Title: FMde-Family Medicine - Dermatology: Acne; Hair/Nail Disorders; Rosacea

Faculty: Jeffrey Miller, M.D., M.B.A.

Original Release Date: July 1, 2020  Expiration Date: July 1, 2023

TOPIC 1: Acne: Pathophysiology and Treatment.

Upon completion of this session, the participant should be able to: ^{GL, COMP}

1. Characterize types of acne lesions and appropriate therapy based on pathophysiology.
2. Differentiate acneiform eruptions from acne vulgaris.
3. Apply appropriate antibiotic recommendations with consideration of patterns of resistance.
4. Employ the use of Isotretinoin as per the AAD recommendations.

TOPIC 2: Hair and Nail Disorders for the Primary Care Provider.

Upon completion of this session, the participant should be able to: ^{GL, COMP}

1. Develop an objective, simplified approach to hair loss.
2. Distinguish the common causes of hair loss.
3. Plan treatment strategies, as per the AAD recommendations, for the common causes of hair loss.
4. Determine the common causes of nail dystrophy in a primary care practice by applying the AAD recommended diagnostic algorithm.
5. Formulate a treatment strategy for nail fold inflammation.

TOPIC 3: Approach to Rosacea and the Red Face.

Upon completion of this session, the participant should be able to:          ^{EBM, COMP}

1. Identify the various types of Rosacea.
2. Distinguish Rosacea from other causes of the “Red Face”.
3. Develop an Evidence-Based treatment plan for Rosacea as per The Cochrane Skin Group Reviews.

Title: FMge-Family Medicine – Geriatrics: Dementia; Delirium; Polymyalgia Rheumatica and GCA

Faculty: Gary H. Oberlender, M.D., F.A.C.P., John W. Pendleton, M.D., F.A.C.P., F.A.C.R.

Original Release Date: July 1, 2020  Expiration Date: July 1, 2023

TOPIC 1: Evaluation and Treatment of Dementia in Seniors.  Upon completion of this session, the participant should be able to:              ^{EBM, COMP}

1. Determine the common causes of cognitive dysfunction and dementia in seniors.
2. Develop an evidence based evaluation of seniors with cognitive dysfunction.
3. Evaluate the relative risks and benefits of available treatment options for dementia in seniors.
4. Distinguish the central role of caregiver education and support in treating seniors with dementia.

TOPIC2: Delirium in the Elderly - Current Concepts.

Upon completion of this session, the participant should be able to: ^{EBM, COMP}

1. Specify diagnostic features and common causes of delirium in seniors.
2. Distinguish the causes of persistent delirium.
3. Use evidence based medicine to formulate treatment approaches to delirious seniors.
4. Recognize treatment options for intermittent agitation using evidence based medicine.

TOPIC 3: Polymyalgia Rheumatica and Giant Cell Arteritis.

Upon completion of this session, the participant should be able to: ^{EBM, COMP}

1. Integrate and relate the typical symptoms, physical findings, and laboratory abnormalities in polymyalgia rheumatica.
2. Use evidence based information to determine the appropriate initial dose of prednisone in patients with PMR.
3. Detect the typical and atypical presentations of GCA.
4. Determine the appropriate indication and technique for temporal artery biopsy.
5. Prescribe the most effective treatment and distinguish the most serious complications of GCA.

Title: FMid-Family Medicine - Infectious Diseases: HIV; STDs; Tuberculosis

Faculty: John Crane, M.D. Ph.D., Stephen J. Gluckman, M.D., F.A.C.P., F.I.D.S.A

Original Release Date: July 1, 2020  Expiration Date: July 1, 2023

TOPIC 1: What Every Primary Care Provider Should Know About HIV.

Upon completion of this session, the participant should be able to: ^{GL, EBM, COMP}

1. Relate the present epidemiology of HIV.
2. Develop an up-to-date understanding of the prognosis for a newly infected person.
3. Assess the major viral and host factors that determine the present approach to the management of a person infected with HIV as per the NIH, CDC & IDSA Guidelines.
4. Determine risk to health care workers and develop a plan to manage an exposed health care worker as per the current CDC and USPSTF Guidelines.

TOPIC 2: Sexually Transmitted Diseases.

Upon completion of this session, the participant should be able to: ^{GL, COMP}

1. Relate the present epidemiology of STDs in this country.
2. Develop a differential diagnosis and a diagnostic and treatment approach for the following STD syndromes based on CDC guidelines:
   1. Urethritis;
   2. Vaginitis;
   3. Genital ulcer(s).
3. Specify the diagnosis and management of syphilis, gonorrhea, chlamydia, herpes simplex, and HPV.
4. Relate the proper use of a condom so that they may properly educate patients.

TOPIC 3:  Tuberculosis: Latent and Active

Primary care providers play a significant part in achieving the target of TB elimination because of their access to high-risk populations in their practices.  Using guidelines from the CDC, ATS and IDSA, an evidence-based approach on diagnosis and treatment will be reviewed.  Upon completion of this session, the participant should be able to: ^{EBM, GL, COMP}

1. Accurately explain to patients, family members, and other health care personnel the difference between active TB and latent TB
2. Skillfully incorporate the use of interferon gamma release assays (IGRA’s) into testing for latent or active TB.
3. Give an example of a special population for which a tuberculin skin test (TST) might still be used instead of an IGRA.
4. Understand the changing epidemiology of non-TB mycobacteria in the U.S

Title: FMph-Family Medicine - Pharmacology: Antibiotic Therapy; Drug-Drug Interactions; Cannabis Pharmacology

Faculty: Benjamin M. Kaplan, M.D., Joel Kravitz, M.D., F.A.C.E.P., F.R.C.P.S.C., Blair Weikert, M.D.

Original Release Date: July 1, 2020  Expiration Date: July 1, 2023

SPECIFIC OBJECTIVES FOR EACH TOPIC:

TOPIC 1: Update in Antibiotic Therapy.

Upon completion of this session, the participant should be able to: ^COMP

1. Appraise the pharmacology and antibacterial spectrum of activity of the newer antibiotics.
2. Assess the indications for use of newer agents based on sites of infection and susceptibility patterns and apply the appropriate drug recommendation to key clinical scenarios as per the IDSA guidelines.
3. Relate the side effects, adverse reactions and important drug-drug interactions affiliated with each antibiotic.

TOPIC 2: Drug-Drug Interactions (DDIs).

Upon completion of this session, the participant should be able to: ^{COMP, GL}

1. Assess the scope of the problem of drug-drug interactions as it pertains to both the outpatient and emergency settings.
2. Explore interactions between prescription and non-prescription medications and review their treatments in the context of the Beers Criteria.
3. Review common drug-drug interactions and their complications commonly seen in the emergency room

TOPIC 3 The Science Behind Cannabis Pharmacology.

Upon completion of this session, the participant should be able to: ^{COMP, EBM}

1. Understand the central mechanism of action for the most common cannabinoids.
2. Define and understand the role of the Endocannabinoid system.
3. Describe the pharmacological effects on the human body through a system-based approach using evidence-based research.
4. Discuss toxicity levels of THC and impact on overall health.
5. Understand the mechanism behind tolerance and dependence.